Evidence map›Paper›PMID 41394343›Full record

ArticleBrain communications2025

Near-lifespan mesoscopic optical imaging of cerebrovascular function reveals age and sex differences in preclinical Alzheimer's disease model.

Noah Schweitzer, Christopher Cover, Howard Aizenstein, Minjie Wu, Alberto Vazquez, Bistra Iordanova

Abstract read
In one paragraph

Article in Brain communications, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Noah SchweitzerDepartment of Bioengineering, University of Pittsburgh, Pittsburgh, PA 15213, United States of America.ORCID https://orcid.org/0000-0003-2959-7851
Christopher CoverDepartment of Bioengineering, University of Pittsburgh, Pittsburgh, PA 15213, United States of America.
Howard AizensteinDepartment of Bioengineering, University of Pittsburgh, Pittsburgh, PA 15213, United States of America.
Minjie WuDepartment of Psychiatry, University of Pittsburgh School of Medicine, Pittsburgh, PA 15213, United States of America.
Alberto VazquezDepartment of Bioengineering, University of Pittsburgh, Pittsburgh, PA 15213, United States of America.
Bistra IordanovaDepartment of Bioengineering, University of Pittsburgh, Pittsburgh, PA 15213, United States of America.

Funding

Cardiovascular Bioengineering Training ProgramT32HL076124 · NHLBI · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI SANJEEV G SHROFF · 2005 to 2026
$7.0M
A Cerebrovascular Basis for Sex Differences in Alzheimer's Disease RiskR01AG067018 · NIA · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI WU, MINJIE · 2020 to 2023
$1.7M
NHLBI NIH HHS T32 HL076124NIA NIH HHS R01 AG067018
6 · The paper itself

Abstract

Growing evidence suggests vascular dysfunction plays a critical role in the early stages of Alzheimer's disease, commonly associated with amyloid-β deposition. This vascular dysfunction is particularly relevant in the context of cerebral amyloid angiopathy, where amyloid-β accumulates within cerebral vessel walls. Notably, sex differences impact progression of both Alzheimer's disease and cerebrovascular dysfunction, with post-menopausal females displaying increased small vessel disease burden and diminished carbon dioxide reactivity compared to older males and pre-menopausal females. Moreover, the cerebrovasculature is a target of sex hormones where they exert influence in numerous vascular functions and pathologies across lifespan. Combined, cerebrovascular dysfunction along with amyloid-β deposition may have differential effects on sex. Despite observational studies in humans, preclinical mechanistic and functional research on sex-specific vascular differences in Alzheimer's disease has been limited. In this near-lifespan longitudinal study, we investigated age and sex-specific neurovascular coupling and carbon dioxide reactivity in a transgenic mouse model expressing chimeric mouse/human amyloid precursor and mutant human presenilin 1 (APP/PS1) and control mice using widefield optical imaging. Neurovascular coupling was probed via whisker stimulation and then vascular reactivity was measured using hypercapnic challenge. During whisker stimulation, neuronal activity was measured through GCaMP6f fluorescence change, while vascular response was quantified via haemoglobin-based optical intrinsic signal. Carbon dioxide reactivity was evaluated by measuring dilatory changes of vessel diameters across the cerebrovascular tree.

Indexed as

Alzheimer’s diseasecerebrovascular reactivityneurovascular couplingsex differencesvascular dysfunction

Identifiers

PMID41394343
PMCPMC12699225

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.